Trial intelligence / Profile preview

Atorvastatin for arterial wall inflammation in chronic kidney disease

NL-OMON22577Recruiting

Sponsor
Amsterdam UMC
Start
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of atorvastatin in chronic kidney disease (CKD), sponsored by Amsterdam UMC. Started Nov 2016; status: recruiting.

02

Drugs

atorvastatin
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NL-OMON22577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call